Top Countries For Rescuing Your Clinical Study

The global contract research organization (CRO) market was valued at $38.4 billion in 2020 and is expected to reach $54.7 billion by 2027. Despite the trend to outsource clinical trials, many studies fail to meet enrollment goals: 80% run over a month behind schedule, costing sponsors $660,000 to $8 million per day of delay, often necessitating a rescue plan.

Choosing the right country can help rescue a troubled study. Prioritize countries with speedy enrollment and streamlined regulatory processes, like those in Eastern Europe. These countries, with a combined population of 256 million, have high recruitment rates and many treatment-naive subjects due to their national healthcare systems.

Eastern Europe also offers lower clinical trial costs. For instance, labor and site fees in Ukraine can be up to 50% lower than in Western and Northern Europe and the US. Enrollment rates are high, resulting in competitive per patient costs: 28% lower than in Western Europe and 47% lower than in the UK. FDA data confirms that Eastern European sites maintain high productivity and regulatory compliance, matching Western standards.

While many countries are worth considering, we will focus on those with which we have the most experience.